Safe, Effective Prescription Mental Wellness. For Everyone. Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist Matthew Baggott and deeptech serial entrepreneur Luke Pustejovsky, Compared to existing psychedelics, our gentler, less euphoric compounds can facilitate psychotherapy, decision-making, and psychological growth while having less need for the expensive clinical monitoring. Our IP includes drug discovery methods, novel molecules, and pharmaceutical preparations. These all focus on one goal: enabling safer take-home prescription empathogens. We believe this will be the key to effective and accessible mental wellness. Tactogen: Effective Prescription Mental Wellness. For Everyone.
| Website | http://www.tactogen.com |
| Employees | 4 (1 on RocketReach) |
| Founded | 2020 |
| Address | 3790 El Camino Real # 510, Palo Alto, California 94306, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Mdma Therapy, Psychedelic Medicine, Innovative Therapeutics, Mental Wellness, Mental Health Treatment, Mental Healthcare, Prescription Drugs, Pharmaceutical Research, Drug Development, Clinical Trials, Treatment Resistant Depression, Anxiety Treatment, Ptsd Treatment, Depression Treatment, Neurological Disorders, Brain Health, Data Science, Neuroscience |
| Competitors | NeuroPace, Medtronic, Boston Scientific, Sientra, Inc., Abbott, Hua Medicine, Elekta, NeuroSigma, Hepion Pharmaceuticals, AcuFocus, Inc. +27 more (view full list) |
Looking for a particular Tactogen employee's phone or email?
Matthew Baggott is the Co-Founder and CEO of Tactogen.
1 people are employed at Tactogen.
Tactogen is based in Palo Alto, California.